Clinical Trial Update: A Real-world Study About the Impact of Siponimod Treatment on Secondary Progressive Multiple Sclerosis Patients in Russia

View source ↗

Summary

A real-world study conducted in Russia assessed the impact of siponimod treatment on patients with secondary progressive multiple sclerosis; the study has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Drugs mentioned

• Siponimod (siponimod)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Secondary Progressive Multiple Sclerosis | Status: COMPLETED